Discover how norcantharidin (NCTD), derived from blister beetles, is revolutionizing liver cancer research through its multi-targeted approach against hepatocellular carcinoma.
Exploring how miR-133a-3p functions as a molecular brake on liver cancer growth and its potential as a diagnostic tool and therapeutic target.
Discover how p62/IMP2-2 protein enables hepatocellular carcinoma to evade apoptosis through IGF2-independent pathways, offering new therapeutic targets.